{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:04:56Z","timestamp":1792087496130,"version":"4.4.0"},"reference-count":160,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Malaria continues to impose a devastating disease burden globally despite control efforts spanning decades. Its elimination has been hindered by parasite and vector complexity and emerging drug and insecticide resistance, along with unremitting barriers to uptake of preventative strategies largely driven by social inequities, cost constraints, and logistical challenges in implementation. This review synthesises current and emerging prevention strategies, including vector control, chemoprevention and immunoprophylaxis. Insecticide-treated nets and indoor residual spraying remain cornerstones of vector control, although their effectiveness is increasingly compromised by widespread insecticide resistance. Chemoprevention, including intermittent preventive treatment in pregnancy and seasonal malaria chemoprevention in children, has proven highly efficacious, yet uptake remains below WHO targets and concerns about drug resistance remain. Recent advances in vaccines, notably RTS,S\/AS01 and R21\/Matrix-M, represent landmark achievements, with large-scale rollouts demonstrating reductions in severe disease and mortality. Novel approaches, such as monoclonal antibodies and genetically modified mosquitoes, offer promising avenues for future prevention. However, challenges remain in ensuring equitable access, sustaining efficacy in the face of evolving parasite and vector biology, and integrating interventions into diverse health systems. This review highlights the need for adaptive, multifaceted approaches to achieve malaria elimination goals.<\/jats:p>","DOI":"10.3390\/pathogens15020137","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:24:36Z","timestamp":1769423076000},"page":"137","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Evolving Landscape of Malaria Prevention Strategies: A Review of Recent Developments"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2822-8659","authenticated-orcid":false,"given":"Yathavi","family":"Charavanamuttu","sequence":"first","affiliation":[{"name":"Faculty of Life Sciences and Medicine, King\u2019s College London, London WC2R 2LS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-5273","authenticated-orcid":false,"given":"Akosua","family":"Agyeman Wamba","sequence":"additional","affiliation":[{"name":"Department of Infection Sciences, King\u2019s College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7342-8348","authenticated-orcid":false,"given":"Andrew W.","family":"Taylor-Robinson","sequence":"additional","affiliation":[{"name":"College of Health Sciences, VinUniversity, Hanoi 100000, Vietnam"},{"name":"Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7652-4236","authenticated-orcid":false,"given":"Temi","family":"Lampejo","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Medicine, King\u2019s College London, London WC2R 2LS, UK"},{"name":"Department of Infection Sciences, King\u2019s College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, December 28). World Malaria Report 2025. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240117822."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(23)01249-7","article-title":"Malaria","volume":"402","author":"Poespoprodjo","year":"2023","journal-title":"Lancet"},{"key":"ref_3","unstructured":"World Health Organization (2025, December 28). Malaria. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2022.12366","article-title":"Diagnosis, Treatment, and Prevention of Malaria in the US","volume":"328","author":"Daily","year":"2022","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12936-022-04301-8","article-title":"Severe malaria","volume":"21","author":"White","year":"2022","journal-title":"Malar. J."},{"key":"ref_6","unstructured":"World Health Organization (2025, December 28). World Malaria Report 2024. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240104440."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Morlino, C., Byrne, I., Achan, J., Baraka, V., Barry, A., Bousema, T., Camara, A., Chacky, F., Chico, R.M., and Clarke, S.E. (2025). Barriers to uptake and implementation of malaria chemoprevention in school-aged children: A stakeholder engagement meeting report. Front. Trop. Dis., 6.","DOI":"10.3389\/fitd.2025.1480907"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pt.2016.11.006","article-title":"Changes in Malaria Epidemiology in Africa and New Challenges for Elimination","volume":"33","author":"Nkumama","year":"2017","journal-title":"Trends Parasitol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11908-023-00805-9","article-title":"Updates on Malaria Epidemiology and Prevention Strategies","volume":"25","author":"Berzosa","year":"2023","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_10","first-page":"2200786","article-title":"Epidemiological investigation of a case of malaria in a non-endemic area, Campo de Gibraltar, Cadiz, Spain, January 2022","volume":"27","year":"2022","journal-title":"Euro Surveill."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Boccolini, D., Menegon, M., Di Luca, M., Toma, L., Severini, F., Marucci, G., D\u2019Amato, S., Caraglia, A., Maraglino, F.P., and Rezza, G. (2020). Non-imported malaria in Italy: Paradigmatic approaches and public health implications following an unusual cluster of cases in 2017. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-08748-9"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2400133","DOI":"10.2807\/1560-7917.ES.2024.29.41.2400133","article-title":"Locally acquired malaria: A retrospective analysis of long-term surveillance data, European France, 1995 to 2022","volume":"29","author":"Delamare","year":"2024","journal-title":"Euro Surveill."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tseroni, M., Baka, A., Kapizioni, C., Snounou, G., Tsiodras, S., Charvalakou, M., Georgitsou, M., Panoutsakou, M., Psinaki, I., and Tsoromokou, M. (2015). Prevention of Malaria Resurgence in Greece through the Association of Mass Drug Administration (MDA) to Immigrants from Malaria-Endemic Regions and Standard Control Measures. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0004215"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tseroni, M., Georgitsou, M., Baka, A., Pinaka, O., Pervanidou, D., Tsironi, M., Bleta, P., Charvalakou, M., Psinaki, I., and Dionysopoulou, M. (2020). The Importance of an Active Case Detection (ACD) Programme for Malaria among Migrants from Malaria Endemic Countries: The Greek Experience in a Receptive and Vulnerable Area. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17114080"},{"key":"ref_15","unstructured":"Centers for Disease Control and Prevention (2025, December 28). Insecticide-Treated Nets, Available online: https:\/\/www.cdc.gov\/malaria\/php\/public-health-strategy\/insecticide-treated-nets.html#:~:text=Insecticide-treated%20bed%20nets%20%28ITNs%29%20are%20a%20form%20of,and%20death%20due%20to%20malaria%20in%20endemic%20regions."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lissenden, N., Armistead, J.S., Gleave, K., Irish, S.R., Martin, J.L., Messenger, L.A., Moore, S.J., Ngufor, C., Protopopoff, N., and Oxborough, R. (2021). Developing Consensus Standard Operating Procedures (SOPs) to Evaluate New Types of Insecticide-Treated Nets. Insects, 13.","DOI":"10.3390\/insects13010007"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0035-9203(94)90268-2","article-title":"Approaches to vector control: New and trusted: 4. Appropriate technology for vector control: Impregnated bed nets, polystyrene beads and fly traps","volume":"88","author":"Curtis","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12936-020-03321-6","article-title":"The fabric of life: What if mosquito nets were durable and widely available but insecticide-free?","volume":"19","author":"Okumu","year":"2020","journal-title":"Malar. J."},{"key":"ref_19","first-page":"CD000363","article-title":"Insecticide-treated bed nets and curtains for preventing malaria","volume":"2","author":"Lengeler","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_20","unstructured":"Roll Back Malaria Partnership (2025, December 28). The Global Malaria Action Plan for a Malaria Free World. Available online: https:\/\/www.afro.who.int\/sites\/default\/files\/2017-06\/Gmapfull.pdf."},{"key":"ref_21","unstructured":"World Health Organization (2025, December 28). 4.1. Insecticide-Treated Nets (ITNs), Guidelines for Malaria Vector Control, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538119\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111281","DOI":"10.1016\/j.jtbi.2022.111281","article-title":"Assessing the impact of insecticide-treated nets in the face of insecticide resistance on malaria control","volume":"555","author":"Ngonghala","year":"2022","journal-title":"J. Theor. Biol."},{"key":"ref_23","first-page":"11","article-title":"Effectiveness of long-lasting insecticidal nets for malaria elimination in Laos (2016\u20132023)","volume":"16","author":"Navalith","year":"2025","journal-title":"Malar. World J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13071-018-2783-y","article-title":"Comparative effectiveness of malaria prevention measures: A systematic review and network meta-analysis","volume":"11","author":"Wangdi","year":"2018","journal-title":"Parasites Vectors"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2214-109X(23)00044-X","article-title":"Vector control for malaria prevention during humanitarian emergencies: A systematic review and meta-analysis","volume":"11","author":"Messenger","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bayou, F.D., Kebede, N., Tsega, Y., Nigussie, S., Legassu, T.D., Muche, A., Muluneh, A.A., and Ayele, F.Y. (2024). Under utilization of long-lasting insecticidal nets (LLINs) is challenging malaria elimination program in Ethiopia: A systematic review and meta-analysis. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18344-w"},{"key":"ref_27","unstructured":"Duguma, D. (2025, December 28). Ethiopia Malaria Elimination Strategic Plan: 2021\u20132025. Available online: http:\/\/www.repository.iphce.org\/bitstream\/handle\/123456789\/1526\/Ethiopia-Malaria-Elimination-Strategic-Plan-2021-2025-Agust-31.pdf?sequence=1."},{"key":"ref_28","first-page":"564","article-title":"Insecticide-Treated Net Use in Sub-Saharan Africa: Systematic Review and Meta-Analysis","volume":"78","author":"Ethgena","year":"2021","journal-title":"Ig. Sanita Pubbl."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00285-023-01949-x","article-title":"Can insecticide resistance increase malaria transmission? A genetics-epidemiology mathematical modeling approach","volume":"87","author":"Gumel","year":"2023","journal-title":"J. Math. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e16090","DOI":"10.7554\/eLife.16090","article-title":"The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa","volume":"5","author":"Churcher","year":"2016","journal-title":"eLife"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4404027","DOI":"10.1155\/2022\/4404027","article-title":"Monitoring of Insecticide Resistance in Anopheles culicifacies in Twelve Districts of Madhya Pradesh, Central India (2017\u20132019)","volume":"2022","author":"Mishra","year":"2022","journal-title":"J. Trop. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100266","DOI":"10.1016\/j.crpvbd.2025.100266","article-title":"Malaria transmission, insecticide resistance and efficacy of insecticide-treated nets in Belabo and Ouami, two localities of the East Region of Cameroon","volume":"7","author":"Talipouo","year":"2025","journal-title":"Curr. Res. Parasitol. Vector-Borne Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/mve.12706","article-title":"Distribution and insecticide resistance profile of the major malaria vector Anopheles funestus group across the African continent","volume":"38","author":"Wangrawa","year":"2024","journal-title":"Med. Vet. Entomol."},{"key":"ref_34","unstructured":"World Health Organization Africa (2025, December 28). Anopheles stephensi (Malaria). Available online: https:\/\/www.afro.who.int\/node\/17733."},{"key":"ref_35","unstructured":"World Health Organization (2025, December 28). WHO Publishes Recommendations on Two New Types of Insecticide-Treated Nets. Available online: https:\/\/www.who.int\/news\/item\/14-03-2023-who-publishes-recommendations-on-two-new-types-of-insecticide-treated-nets."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Barker, T.H., Stone, J.C., Hasanoff, S., Price, C., Kabaghe, A., and Munn, Z. (2023). Effectiveness of dual active ingredient insecticide-treated nets in preventing malaria: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0289469"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12936-024-05020-y","article-title":"Will a lack of fabric durability be their downfall? Impact of textile durability on the efficacy of three types of dual-active-ingredient long-lasting insecticidal nets: A secondary analysis on malaria prevalence and incidence from a cluster-randomized tr","volume":"23","author":"Lukole","year":"2024","journal-title":"Malar. J."},{"key":"ref_38","first-page":"CD000363","article-title":"Insecticide-treated nets for preventing malaria","volume":"11","author":"Pryce","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40249-022-01005-8","article-title":"Effectiveness of indoor residual spraying on malaria control: A systematic review and meta-analysis","volume":"11","author":"Zhou","year":"2022","journal-title":"Infect. Dis. Poverty"},{"key":"ref_40","first-page":"CD012688","article-title":"Indoor residual spraying for preventing malaria in communities using insecticide-treated nets","volume":"1","author":"Pryce","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"h99","DOI":"10.1136\/bmj.h99","article-title":"Mosquito repellents for travellers","volume":"350","author":"Stanczyk","year":"2015","journal-title":"BMJ"},{"key":"ref_42","first-page":"CD015422","article-title":"Topical repellents for malaria prevention","volume":"8","author":"Wagah","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1475-2875-13-446","article-title":"Are topical insect repellents effective against malaria in endemic populations? A systematic review and meta-analysis","volume":"13","author":"Wilson","year":"2014","journal-title":"Malar. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S1473-3099(16)30148-7","article-title":"Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: A cluster randomised controlled trial","volume":"16","author":"Sluydts","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_45","first-page":"10","article-title":"Repellency Effects of Essential Oils of Myrtle (Myrtus communis), Marigold (Calendula officinalis) Compared with DEET against Anopheles stephensi on Human Volunteers","volume":"5","author":"Tavassoli","year":"2011","journal-title":"Iran. J. Arthropod-Borne Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00436-006-0184-1","article-title":"Repellency effect of forty-one essential oils against Aedes, Anopheles, and Culex mosquitoes","volume":"99","author":"Amer","year":"2006","journal-title":"Parasitol. Res."},{"key":"ref_47","first-page":"1423","article-title":"Efficacy of repellent products against caged and free flying Anopheles stephensi mosquitoes","volume":"36","author":"Trongtokit","year":"2005","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bohbot, J.D., and Dickens, J.C. (2010). Insect Repellents: Modulators of Mosquito Odorant Receptor Activity. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012138"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2018.10.053","article-title":"Insect repellents: An updated review for the clinician","volume":"88","author":"Nguyen","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4269\/ajtmh.2001.65.285","article-title":"Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy","volume":"65","author":"McGready","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/10915810290096559","article-title":"Human Exposures to N,N-diethyl-m-toluamide Insect Repellents Reported to the American Association of Poison Control Centers 1993\u20131997","volume":"21","author":"Bell","year":"2002","journal-title":"Int. J. Toxicol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/mve.12188","article-title":"New repellent effective against African malaria mosquito Anopheles gambiae: Implications for vector control","volume":"30","author":"Hodson","year":"2016","journal-title":"Med. Vet. Entomol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(16)30207-9","article-title":"A new perspective on the application of mosquito repellents","volume":"16","author":"Moore","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/mve.12068","article-title":"Insecticide-treated clothes for the control of vector-borne diseases: A review on effectiveness and safety","volume":"28","author":"Banks","year":"2014","journal-title":"Med. Vet. Entomol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJMoa2501628","article-title":"Permethrin-Treated Baby Wraps for the Prevention of Malaria","volume":"393","author":"Boyce","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_56","first-page":"CD012736","article-title":"Larviciding to prevent malaria transmission","volume":"8","author":"Choi","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12936-024-05236-y","article-title":"Larviciding for malaria control and elimination in Africa","volume":"24","author":"Newby","year":"2025","journal-title":"Malar. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19694","DOI":"10.1038\/s41598-022-24055-2","article-title":"The control of malaria vectors in rice fields: A systematic review and meta-analysis","volume":"12","author":"Chan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_59","first-page":"CD008923","article-title":"Mosquito larval source management for controlling malaria","volume":"8","author":"Tusting","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_60","first-page":"395","article-title":"Control of vectors and incidence of malaria in an irrigated settlement scheme in Sri Lanka by using the insect growth regulator pyriproxyfen","volume":"20","author":"Yapabandara","year":"2004","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0001-706X(01)00178-4","article-title":"Control of malaria vectors with the insect growth regulator pyriproxyfen in a gem-mining area in Sri Lanka","volume":"80","author":"Yapabandara","year":"2001","journal-title":"Acta Trop."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/1365-2656.13965","article-title":"A meta-analysis reveals that dragonflies and damselflies can provide effective biological control of mosquitoes","volume":"92","author":"Priyadarshana","year":"2023","journal-title":"J. Anim. Ecol."},{"key":"ref_63","first-page":"CD008923","article-title":"Mosquito aquatic habitat modification and manipulation interventions to control malaria","volume":"11","author":"Martello","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pt.2024.04.010","article-title":"Curing mosquitoes with genetic approaches for malaria control","volume":"40","author":"Kefi","year":"2024","journal-title":"Trends Parasitol."},{"key":"ref_65","unstructured":"Centers for Disease Control and Prevention (2025, December 28). Genetically Modified Mosquitoes, Available online: https:\/\/www.cdc.gov\/mosquitoes\/mosquito-control\/genetically-modified-mosquitoes.html."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/s41467-022-30606-y","article-title":"Transgenic Anopheles mosquitoes expressing human PAI-1 impair malaria transmission","volume":"13","author":"Pascini","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12936-024-05179-4","article-title":"Post-release monitoring pathway for the deployment of gene drive-modified mosquitoes for malaria control in Africa","volume":"23","author":"Ogoyi","year":"2024","journal-title":"Malar. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2302504","DOI":"10.1080\/07853890.2024.2302504","article-title":"Transforming malaria prevention and control: The prospects and challenges of gene drive technology for mosquito management","volume":"55","author":"Tajudeen","year":"2023","journal-title":"Ann. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Kormos, A., Dimopoulos, G., Bier, E., Lanzaro, G.C., Marshall, J.M., and James, A.A. (2023). Conceptual risk assessment of mosquito population modification gene-drive systems to control malaria transmission: Preliminary hazards list workshops. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1261123"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.adf8141","article-title":"Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes","volume":"381","author":"Huang","year":"2023","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"109466","DOI":"10.1016\/j.mbs.2025.109466","article-title":"Assessing the impact of the Wolbachia-based control of malaria","volume":"387","author":"Qu","year":"2025","journal-title":"Math. Biosci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Mushtaq, I., Sarwar, M.S., Chaudhry, A., Shah, S.A.H., and Ahmad, M.M. (2024). Updates on traditional methods for combating malaria and emerging Wolbachia-based interventions. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1330475"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12936-024-04867-5","article-title":"Making the most of malaria chemoprevention","volume":"23","author":"Littmann","year":"2024","journal-title":"Malar. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2352-4642(20)30127-9","article-title":"Treatment and prevention of malaria in children","volume":"4","author":"Ashley","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12936-022-04115-8","article-title":"Malaria chemoprevention and drug resistance: A review of the literature and policy implications","volume":"21","author":"Plowe","year":"2022","journal-title":"Malar. J."},{"key":"ref_76","unstructured":"World Health Organization (2025, December 28). Updated WHO Recommendations for Malaria Chemoprevention Among Children and Pregnant Women. Available online: https:\/\/www.who.int\/news\/item\/03-06-2022-Updated-WHO-recommendations-for-malaria-chemoprevention-among-children-and-pregnant-women."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4314\/gmj.v56i2.2","article-title":"Effectiveness of seasonal malaria chemoprevention in reducing under-five malaria morbidity and mortality in the Savannah Region, Ghana","volume":"56","author":"Adjei","year":"2022","journal-title":"Ghana Med. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.pt.2022.05.003","article-title":"Pharmacokinetic considerations in seasonal malaria chemoprevention","volume":"38","author":"Chotsiri","year":"2022","journal-title":"Trends Parasitol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Cairns, M., Ceesay, S.J., Sagara, I., Zongo, I., Kessely, H., Gamougam, K., Diallo, A., Ogboi, J.S., Moroso, D., and Van Hulle, S. (2021). Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case\u2013control studies in 5 countries. PLoS Med., 18.","DOI":"10.1371\/journal.pmed.1003727"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4269\/ajtmh.23-0481","article-title":"Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention","volume":"110","author":"Thwing","year":"2024","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(24)00746-1","article-title":"Effectiveness of sulfadoxine\u2013pyrimethamine plus amodiaquine and dihydroartemisinin\u2013piperaquine for seasonal malaria chemoprevention in Uganda: A three-arm, open-label, non-inferiority and superiority, cluster-randomised, controlled trial","volume":"25","author":"Nuwa","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.2147\/IDR.S375197","article-title":"Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa","volume":"15","author":"Nikiema","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_83","unstructured":"World Health Organization (2025, December 28). WHO Guidelines for Malaria. Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/26a6af2d-060c-4449-8207-1f25e63c6cc3\/content."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1016\/S2214-109X(20)30325-9","article-title":"Preventive malaria treatment among school-aged children in sub-Saharan Africa: A systematic review and meta-analyses","volume":"8","author":"Cohee","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2214-109X(23)00492-8","article-title":"Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: A systematic review and individual patient data meta-analysis of randomised controlled trials","volume":"12","author":"Phiri","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Cairns, M., Carneiro, I., Milligan, P., Owusu-Agyei, S., Awine, T., Gosling, R., Greenwood, B., and Chandramohan, D. (2008). Duration of Protection against Malaria and Anaemia Provided by Intermittent Preventive Treatment in Infants in Navrongo, Ghana. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002227"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Cairns, M., Gosling, R., Carneiro, I., Gesase, S., Mosha, J.F., Hashim, R., Kaur, H., Lemnge, M., Mosha, F.W., and Greenwood, B. (2010). Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009467"},{"key":"ref_88","unstructured":"Bestgen, B. (2025, December 28). Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371-LAI(QSC300760). Available online: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-mmv371-laiqsc300760\/."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.22-0766","article-title":"Mass Drug Administration to Reduce Malaria Transmission: A Systematic Review and Meta-Analysis","volume":"110","author":"Schneider","year":"2024","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa2411262","article-title":"Ivermectin to Control Malaria\u2014A Cluster-Randomized Trial","volume":"393","author":"Chaccour","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12936-024-05229-x","article-title":"Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique","volume":"24","author":"Baker","year":"2025","journal-title":"Malar. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"24224","DOI":"10.1038\/s41598-024-75369-2","article-title":"Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso","volume":"14","author":"Bohissou","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/s41467-025-57726-5","article-title":"Decreased dihydroartemisinin-piperaquine protection against recurrent malaria associated with Plasmodium falciparum plasmepsin 3 copy number variation in Africa","volume":"16","author":"Recker","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Greenwood, B., and Schellenberg, D. (2022). Chemoprevention for the Populations of Malaria Endemic Africa. Diseases, 10.","DOI":"10.3390\/diseases10040101"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12936-025-05401-x","article-title":"Seasonal malaria chemoprevention in northern Mozambique: A cost-effectiveness analysis","volume":"24","author":"Canana","year":"2025","journal-title":"Malar. J."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Senn, N., Rarau, P., Stanisic, D.I., Robinson, L., Barnadas, C., Manong, D., Salib, M., Iga, J., Tarongka, N., and Ley, S. (2012). Intermittent Preventive Treatment for Malaria in Papua New Guinean Infants Exposed to Plasmodium falciparum and P. vivax: A Randomized Controlled Trial. PLoS Med., 9.","DOI":"10.1371\/annotation\/de06fdd3-c263-416c-8b5f-291f9c474558"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/pao.2018.13","article-title":"Control of Plasmodium vivax malaria by mass chemoprevention with primaquine","volume":"4","author":"Kim","year":"2018","journal-title":"Parasitol. Open"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4269\/ajtmh.22-0727","article-title":"Mass Relapse Prevention to Reduce Transmission of Plasmodium vivax\u2014 A Systematic Review","volume":"110","author":"Shah","year":"2024","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_99","unstructured":"World Health Organization (2025, December 28). Malaria Vaccines (RTS,S and R21). Available online: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/q-a-on-rts-s-malaria-vaccine."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/23744235.2023.2274897","article-title":"Monoclonal antibodies for the prevention of Plasmodium falciparum malaria: A multi-target approach?","volume":"56","author":"Lampejo","year":"2024","journal-title":"Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"RTS,S Clinical Trials Partnership (2015). Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial. Lancet, 386, 31\u201345.","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/S1473-3099(23)00126-3","article-title":"RTS,S\/AS01 malaria vaccine-proven safe and effective?","volume":"23","author":"Benn","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zoa, J.A., Njemguie Linjouom, R.M., Nyangono Ndongo, M., and Nkeck, J.R. (2025). Safety of RTS,S\/AS01E vaccine for malaria in African children aged 5 to 17 months: A systematic review and meta-analysis of randomized controlled trials. PLoS Glob. Public Health, 5.","DOI":"10.1371\/journal.pgph.0004387"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: A phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40794-024-00222-3","article-title":"A landscape review of malaria vaccine candidates in the pipeline","volume":"10","author":"Tajudeen","year":"2024","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_106","unstructured":"UNICEF (2025, December 28). Gavi and UNICEF Announce Equitable Pricing Deal for Malaria Vaccine to Protect 7 Million More Children by End of Decade. Available online: https:\/\/www.unicef.org\/press-releases\/gavi-and-unicef-announce-equitable-pricing-deal-malaria-vaccine-protect-7-million#:~:text=As%20of%20November%202025%2C%20over,thus%20far%20introduced%20in%202025."},{"key":"ref_107","unstructured":"European Commission (2025, December 28). Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium. Available online: https:\/\/cordis.europa.eu\/project\/id\/101190695."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pt.2024.12.015","article-title":"Genetically attenuated parasites show promise as a next-generation malaria vaccine","volume":"41","author":"Hafalla","year":"2025","journal-title":"Trends Parasitol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","article-title":"Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite","volume":"391","author":"Lamers","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-024-03347-2","article-title":"Single immunization with genetically attenuated Pf\u2206mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: A placebo-controlled randomized trial","volume":"31","author":"Roozen","year":"2025","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12936-021-03888-8","article-title":"Combining malaria vaccination with chemoprevention: A promising new approach to malaria control","volume":"20","author":"Greenwood","year":"2021","journal-title":"Malar. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1473-3099(24)00752-7","article-title":"Safety and efficacy of the blood-stage malaria vaccine RH5.1\/Matrix-M in Burkina Faso: Interim results of a double-blind, randomised, controlled, phase 2b trial in children","volume":"25","author":"Natama","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S2666-5247(22)00113-6","article-title":"Is low-dose tafenoquine combined with dihydroartemisinin-piperaquine a potential risk factor for Plasmodium vivax resistance to 8-aminoquinolines?","volume":"3","author":"Lampejo","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Veiga, G.T.S.D., Moriggi, M.R., Vettorazzi, J.F., M\u00fcller-Santos, M., and Albrecht, L. (2023). Plasmodium vivax vaccine: What is the best way to go?. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.910236"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Bennett, J.W., Yadava, A., Tosh, D., Sattabongkot, J., Komisar, J., Ware, L.A., McCarthy, W.F., Cowden, J.J., Regules, J., and Spring, M.D. (2016). Phase 1\/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001\/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004423"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2011.09-0516","article-title":"Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51","volume":"84","author":"Palacios","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41467-022-29226-3","article-title":"Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine","volume":"13","author":"Caicedo","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e93683","DOI":"10.1172\/jci.insight.93683","article-title":"Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41541-018-0083-3","article-title":"Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial","volume":"3","author":"Singh","year":"2018","journal-title":"npj Vaccines"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Wu, Y., Ellis, R.D., Shaffer, D., Fontes, E., Malkin, E.M., Mahanty, S., Fay, M.P., Narum, D., Rausch, K., and Miles, A.P. (2008). Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002636"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Noviyanti, R., Coutrier, F., Utami, R.A.S., Trimarsanto, H., Tirta, Y.K., Trianty, L., Kusuma, A., Sutanto, I., Kosasih, A., and Kusriastuti, R. (2015). Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003739"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Lo, E., Hemming-Schroeder, E., Yewhalaw, D., Nguyen, J., Kebede, E., Zemene, E., Getachew, S., Tushune, K., Zhong, D., and Zhou, G. (2017). Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005806"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0140-6736(23)01553-2","article-title":"Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): A multicentre, open-label, superiority randomised controlled trial","volume":"402","author":"Thriemer","year":"2023","journal-title":"Lancet"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41541-025-01229-3","article-title":"Malaria bivalent viral vectored vaccine protects against Plasmodium falciparum and vivax and blocks parasite transmission","volume":"10","author":"Yamamoto","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_125","unstructured":"Adegnika, A.A. (2025, December 28). Pan-Malaria Transmission-Blocking Vaccine AnAPN1 (PamTBVac), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05905432."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"102525","DOI":"10.1016\/j.parint.2021.102525","article-title":"Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation","volume":"87","author":"Tachibana","year":"2022","journal-title":"Parasitol. Int."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Ott, A.C., Loll, P.J., and Burns, J.M. (2025). An mRNA Vaccine Expressing Blood-Stage Malaria Antigens Induces Complete Protection Against Lethal Plasmodium yoelii. Vaccines, 13.","DOI":"10.3390\/vaccines13070702"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s15010-024-02196-y","article-title":"Malaria vaccine efficacy, safety, and community perception in Africa: A scoping review of recent empirical studies","volume":"52","author":"Chutiyami","year":"2024","journal-title":"Infection"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Sulaiman, S.K., Musa, M.S., Tsiga-Ahmed, F.I., Dayyab, F.M., Sulaiman, A.K., and Bako, A.T. (2022). A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs). PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0278224"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12936-025-05384-9","article-title":"Community readiness and acceptance for the implementation of the malaria vaccine among caretakers of at-risk children in sub-Saharan Africa: A systematic review and meta-analysis","volume":"24","author":"Kigongo","year":"2025","journal-title":"Malar. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e70205","DOI":"10.1002\/iid3.70205","article-title":"Determinants of Malaria Vaccine Acceptance: A Systematic Review and Meta-Analysis of Awareness, Acceptance, Hesitancy, and Willingness to Pay","volume":"13","author":"Bushi","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"ltaa007","DOI":"10.1093\/immadv\/ltaa007","article-title":"Recent advances in immunotherapies against infectious diseases","volume":"1","author":"Ramamurthy","year":"2021","journal-title":"Immunother. Adv."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-Globulin and Acquired Immunity to Human Malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"ref_135","unstructured":"World Health Organization (2025, December 28). Monoclonal Antibodies for Malaria Prevention. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240070981."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e0007123","DOI":"10.1128\/cmr.00071-23","article-title":"Vaccines and monoclonal antibodies: New tools for malaria control","volume":"37","author":"Miura","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa2034031","article-title":"A Monoclonal Antibody for Malaria Prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(22)00793-9","article-title":"Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): A phase 1, adaptive trial","volume":"23","author":"Lyke","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","article-title":"Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali","volume":"387","author":"Kayentao","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1038\/s41591-025-03739-y","article-title":"Anti-sporozoite monoclonal antibody for malaria prevention: Secondary efficacy outcome of a phase 2 randomized trial","volume":"31","author":"Skinner","year":"2025","journal-title":"Nat. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2203067","article-title":"Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria","volume":"387","author":"Wu","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","article-title":"Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria","volume":"390","author":"Kayentao","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_143","unstructured":"National Institute of Allergy and Infectious Diseases (2025, December 28). Anti-Malaria MAb in Kenyan Children, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05400655."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-023-02659-z","article-title":"A candidate antibody drug for prevention of malaria","volume":"30","author":"Williams","year":"2024","journal-title":"Nat. Med."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Lyke, K.E., Berry, A.A., Laurens, M.B., Winkler, J., Joshi, S., Koudjra, A.R., Butler, L., Billingsley, P.F., Pascini, T., and Patil, A. (2025). Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: A first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial. Lancet Infect. Dis., Online ahead of print.","DOI":"10.1016\/S1473-3099(25)00481-5"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S1473-3099(22)00428-5","article-title":"Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: A single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults","volume":"22","author":"Smit","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/infdis\/jiad101","article-title":"Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission","volume":"228","author":"Challenger","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_148","first-page":"101985","article-title":"A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade","volume":"6","author":"Patel","year":"2025","journal-title":"Cell Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.1038\/s41467-024-53848-4","article-title":"Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages","volume":"15","author":"Winnicki","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Wang, L.T., Pereira, L.S., Kiyuka, P.K., Sch\u00f6n, A., Kisalu, N.K., Vistein, R., Dillon, M., Bonilla, B.G., Molina-Cruz, A., and Barillas-Mury, C. (2021). Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1010133"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tmaid.2011.09.004","article-title":"Travel clinic communication and non-adherence to malaria chemoprophylaxis","volume":"9","author":"Farquharson","year":"2011","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"See, K.C. (2022). Vaccination for the Prevention of Infection among Immunocompromised Patients: A Concise Review of Recent Systematic Reviews. Vaccines, 10.","DOI":"10.3390\/vaccines10050800"},{"key":"ref_153","unstructured":"Bloland, P.B., and Williams , H.A. (2025, December 28). Malaria Control During Mass Population Movements and Natural Disasters, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK221155\/."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e081982","DOI":"10.1136\/bmjopen-2023-081982","article-title":"Community engagement approaches for malaria prevention, control and elimination: A scoping review","volume":"14","author":"Awasthi","year":"2024","journal-title":"BMJ Open"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11604\/pamj.2021.39.151.25685","article-title":"Knowledge of malaria control and attitudes towards community involvement among female community volunteers: Effect of capacity building in a rural community, southeast Nigeria","volume":"39","author":"Agu","year":"2021","journal-title":"Pan Afr. Med. J."},{"key":"ref_156","unstructured":"Malaria Consortium (2025, December 28). Community Engagement for Vector Borne Disease Control in Asia Pacific. Available online: https:\/\/www.apmen.org\/sites\/default\/files\/all_resources\/Community%20Engagement%20for%20VBDC%20in%20Asia%20Pacific_Tools%2C%20Approaches%2C%20and%20Lessons_APMEN%20case%20study.pdf."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12936-019-2878-8","article-title":"What is community engagement and how can it drive malaria elimination? Case studies and stakeholder interviews","volume":"18","author":"Baltzell","year":"2019","journal-title":"Malar. J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"100307","DOI":"10.1016\/j.crpvbd.2025.100307","article-title":"Assessing the role of community involvement and capacity building in larviciding applications for malaria control in Africa: A scoping review","volume":"8","author":"Shirima","year":"2025","journal-title":"Curr. Res. Parasitol. Vector-Borne Dis."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Jimeno-Maroto, I., Galindo, M.S., Miller, J.B., Lambert, Y., Carboni, C., Bardon, T., Plessis, L., Vreden, S., Suarez-Mutis, M., and Douine, M. (2024). Community engagement in mobile and hard-to-reach populations: A community-based intervention for malaria elimination in a tri-national region of the Guiana Shield. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1377966"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1038\/s41591-024-03193-2","article-title":"A community engagement framework to accelerate the uptake of malaria vaccines in Africa","volume":"30","author":"Dereje","year":"2024","journal-title":"Nat. Med."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/2\/137\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:23:57Z","timestamp":1769505837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/2\/137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":160,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["pathogens15020137"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15020137","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]}}}